161 related articles for article (PubMed ID: 31308956)
1. Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma.
Torrigiani F; Romanelli G; Roccabianca P; Treggiari E
JFMS Open Rep; 2019; 5(2):2055116919857870. PubMed ID: 31308956
[TBL] [Abstract][Full Text] [Related]
2. Oral histiocytic sarcoma in a cat.
Néčová S; North S; Cahalan S; Das S
JFMS Open Rep; 2020; 6(2):2055116920971248. PubMed ID: 33282334
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival in a cat with tonsillar squamous cell carcinoma treated with surgery and chemotherapy.
Treggiari E; Romanelli G; Ferro S; Roccabianca P
JFMS Open Rep; 2021; 7(1):2055116920984387. PubMed ID: 33614106
[TBL] [Abstract][Full Text] [Related]
4. Current trials and new aspects in soft tissue sarcoma of adults.
Issels RD; Schlemmer M
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
[TBL] [Abstract][Full Text] [Related]
5. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
[TBL] [Abstract][Full Text] [Related]
6. Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients.
Wang B; Yu X; Xu S; Xu M
Medicine (Baltimore); 2016 Jan; 95(4):e2611. PubMed ID: 26825914
[TBL] [Abstract][Full Text] [Related]
7. Primary diaphragmatic undifferentiated pleomorphic sarcoma in a cat.
Bonazzi I; Morabito S; Brunetti B; Nicoli S; Valenti P
JFMS Open Rep; 2021; 7(1):20551169211018992. PubMed ID: 34158969
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX).
Sundby Hall K; Bruland ØS; Bjerkehagen B; Zaikova O; Engellau J; Hagberg O; Hansson L; Hagberg H; Ahlström M; Knobel H; Papworth K; Zemmler M; Goplen D; Bauer HCF; Eriksson M
Eur J Cancer; 2018 Aug; 99():78-85. PubMed ID: 29929092
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.
Edmonson JH; Petersen IA; Shives TC; Mahoney MR; Rock MG; Haddock MG; Sim FH; Maples WJ; O'Connor MI; Gunderson LL; Foo ML; Pritchard DJ; Buckner JC; Stafford SL
Cancer; 2002 Feb; 94(3):786-92. PubMed ID: 11857314
[TBL] [Abstract][Full Text] [Related]
10. Treating soft tissue sarcomas with adjuvant chemotherapy.
Patrikidou A; Domont J; Cioffi A; Le Cesne A
Curr Treat Options Oncol; 2011 Mar; 12(1):21-31. PubMed ID: 21384115
[TBL] [Abstract][Full Text] [Related]
11. A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.
Schmitt T; Lehner B; Kasper B; Bischof M; Roeder F; Dietrich S; Dimitrakopoulou-Strauss A; Strauss LG; Mechtersheimer G; Wuchter P; Ho AD; Egerer G
BMC Cancer; 2011 Dec; 11():510. PubMed ID: 22152120
[TBL] [Abstract][Full Text] [Related]
12. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
13. Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study.
Hall KS; Bruland ØS; Bjerkehagen B; Lidbrink E; Jebsen N; Hagberg H; Papworth K; Hagberg O; Trovik C; Bauer H; Eriksson M
Clin Sarcoma Res; 2020 Nov; 10(1):22. PubMed ID: 33292545
[TBL] [Abstract][Full Text] [Related]
14. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
Trovik CS;
Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
[TBL] [Abstract][Full Text] [Related]
16. Results of preoperative neoadjuvant chemotherapy and surgery in the management of patients with soft tissue sarcoma.
Rahóty P; Kónya A
Eur J Surg Oncol; 1993 Dec; 19(6):641-5. PubMed ID: 8270058
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
Woll PJ; Reichardt P; Le Cesne A; Bonvalot S; Azzarelli A; Hoekstra HJ; Leahy M; Van Coevorden F; Verweij J; Hogendoorn PC; Ouali M; Marreaud S; Bramwell VH; Hohenberger P;
Lancet Oncol; 2012 Oct; 13(10):1045-54. PubMed ID: 22954508
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials.
Spunt SL; Francotte N; De Salvo GL; Chi YY; Zanetti I; Hayes-Jordan A; Kao SC; Orbach D; Brennan B; Weiss AR; van Noesel MM; Million L; Alaggio R; Parham DM; Kelsey A; Randall RL; McCarville MB; Bisogno G; Hawkins DS; Ferrari A
Eur J Cancer; 2019 May; 112():98-106. PubMed ID: 30954717
[TBL] [Abstract][Full Text] [Related]
19. Recurrent Leiomyosarcoma With Malignant Transformation.
Malaviarachchi S; Balawardana J; Senanayake A; Perera R; Liyanage S
Cureus; 2021 Jan; 13(1):e12672. PubMed ID: 33604210
[TBL] [Abstract][Full Text] [Related]
20. Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study.
Tian Z; Wang J; Yang J; Zhang P; Wang X; Zhang F; Li P; Yao W
Invest New Drugs; 2021 Dec; 39(6):1724-1731. PubMed ID: 34156595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
